Published in J Endocrinol on March 31, 2011
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol (2013) 0.99
Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. PLoS One (2012) 0.96
Interaction of aryl hydrocarbon receptor-interacting protein-like 1 with the farnesyl moiety. J Biol Chem (2013) 0.85
The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease. J Neurochem (2015) 0.83
Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the γ-Subunit of Its Client. J Biol Chem (2016) 0.81
The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α. PLoS One (2011) 0.79
Pituitary gland: New pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol (2012) 0.77
Familial pituitary apoplexy as the only presentation of a novel AIP mutation. Endocr Relat Cancer (2013) 0.76
Clinical and genetic aspects of familial isolated pituitary adenomas. Clinics (Sao Paulo) (2012) 0.76
Signaling network map of the aryl hydrocarbon receptor. J Cell Commun Signal (2016) 0.75
NMR resonance assignments of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) in complex with a farnesyl ligand. Biomol NMR Assign (2017) 0.75
A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma. Endocrinol Diabetes Metab Case Rep (2014) 0.75
An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene. Endocrinol Diabetes Metab Case Rep (2015) 0.75
Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells. Pituitary (2016) 0.75
Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas? Genet Test Mol Biomarkers (2015) 0.75
Unique structural features of the AIPL1-FKBP domain that support prenyl lipid binding and underlie protein malfunction in blindness. Proc Natl Acad Sci U S A (2017) 0.75
In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction & stability and is associated with gigantism. Eur J Endocrinol (2017) 0.75
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab (2002) 3.43
AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med (2011) 3.14
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet (2005) 2.85
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem (2005) 1.83
AMPK as a mediator of hormonal signalling. J Mol Endocrinol (2009) 1.53
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One (2008) 1.49
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab (2008) 1.42
The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Res (2006) 1.31
Expanding role of AMPK in endocrinology. Trends Endocrinol Metab (2006) 1.29
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms. Endocr Relat Cancer (2008) 1.25
Theobromine inhibits sensory nerve activation and cough. FASEB J (2004) 1.15
Alterations in adipose tissue during critical illness: An adaptive and protective response? Am J Respir Crit Care Med (2010) 1.13
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line. Neuroendocrinology (2007) 1.11
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB J (2008) 1.11
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat (2012) 1.06
Ghrelin, the peripheral hunger hormone. Ann Med (2007) 1.02
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab (2005) 1.02
A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J Clin Endocrinol Metab (2013) 1.02
Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation. J Clin Endocrinol Metab (2013) 1.02
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat (2010) 1.01
The role of AMP-activated protein kinase in obesity. Front Horm Res (2008) 1.01
Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol (2005) 1.00
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab (2008) 1.00
Novel pathway for somatostatin analogs in patients with acromegaly. Trends Endocrinol Metab (2012) 0.98
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. J Clin Endocrinol Metab (2012) 0.98
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet (2013) 0.98
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary (2011) 0.97
Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. PLoS One (2012) 0.96
The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J (2011) 0.95
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol (2014) 0.95
Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity (Silver Spring) (2009) 0.94
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations. Clin Endocrinol (Oxf) (2008) 0.94
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab (2010) 0.94
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J Clin Endocrinol Metab (2004) 0.94
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab (2015) 0.93
Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists. Eur J Endocrinol (2009) 0.93
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol (2009) 0.91
Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines. J Mol Endocrinol (2012) 0.90
Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab (2014) 0.90
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes. Biochem Pharmacol (2010) 0.89
Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients. J Clin Endocrinol Metab (2006) 0.88
Ghrelin in neuroendocrine organs and tumours. Pituitary (2007) 0.88
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) (2002) 0.88
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab (2015) 0.86
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol (2014) 0.86
Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab (2010) 0.86
The role of somatostatin analogues in the treatment of neuroendocrine tumours. Mol Cell Endocrinol (2007) 0.86
AIP gene and familial isolated pituitary adenomas. Mol Cell Endocrinol (2010) 0.86
Ghrelin in obesity and endocrine diseases. Mol Cell Endocrinol (2011) 0.86
Cell cycle dysregulation in pituitary oncogenesis. Front Horm Res (2004) 0.86
Ghrelin and cardiovascular health. Curr Opin Pharmacol (2006) 0.86
Cyclins and their related proteins in pituitary tumourigenesis. Mol Cell Endocrinol (2010) 0.86
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab (2012) 0.86
Appetite and metabolic effects of ghrelin and cannabinoids: involvement of AMP-activated protein kinase. Vitam Horm (2008) 0.85
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol (2006) 0.85
Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology. Prog Brain Res (2010) 0.85
Genetics of pituitary adenomas. Front Horm Res (2013) 0.85
MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas. Endocrine (2010) 0.85
Specific electrocardiographic features associated with Cushing's disease. Clin Endocrinol (Oxf) (2011) 0.84
The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord (2011) 0.84
PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor. Clin Endocrinol (Oxf) (2006) 0.83
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. Clin Endocrinol (Oxf) (2003) 0.83
Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol (2014) 0.82
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas. Clin Endocrinol (Oxf) (2007) 0.82
Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. J Endocrinol (2009) 0.82
Molecular genetics of the aip gene in familial pituitary tumorigenesis. Prog Brain Res (2010) 0.82
Oncogene-induced senescence in pituitary adenomas and carcinomas. Hormones (Athens) (2012) 0.82
Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker. Stress (2012) 0.81
Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. Endocr Relat Cancer (2012) 0.81
Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol Cell Endocrinol (2012) 0.80
Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes. Peptides (2011) 0.80
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus. J Endocrinol (2013) 0.80
Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening. Arq Bras Endocrinol Metabol (2010) 0.80
Pathogenesis of vascular complications in Cushing's syndrome. Hormones (Athens) (2012) 0.79
Akting and cycling: a tale of the pituitary. Horm Res (2004) 0.79
HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients. Nephrol Dial Transplant (2008) 0.79
Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice. Endocrinology (2014) 0.79
The role of ghrelin in weight-regulation disorders: implications in clinical practice. Hormones (Athens) (2015) 0.78
Refeeding David Blaine--studies after a 44-day fast. N Engl J Med (2005) 0.78
The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors. Pituitary (2002) 0.78
Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab (2014) 0.78
Protein western array analysis in human pituitary tumours: insights and limitations. Endocr Relat Cancer (2008) 0.78
[Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome]. Orv Hetil (2005) 0.77
Measurement of AMP-activated protein kinase activity and expression in response to ghrelin. Methods Enzymol (2012) 0.76
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas. J Clin Endocrinol Metab (2003) 0.76
Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly? J Clin Endocrinol Metab (2013) 0.76
The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release. FASEB J (2013) 0.76
Macro- and micronutrient losses and nutritional status resulting from 44 days of total fasting in a non-obese man. Nutrition (2006) 0.76
The potential role of D(2) dopamine receptors as a target in the management of neuroendocrine tumors. Cancer Biol Ther (2008) 0.75
ACTH-secreting Crooke cell carcinoma of the pituitary. Eur J Clin Invest (2012) 0.75
Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab (2008) 0.75
[Therapy in acromegaly]. Orv Hetil (2004) 0.75
[Ghrelin--a hormone with multiple functions]. Orv Hetil (2005) 0.75
Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: Impact of a multi-disciplinary team. Neurol India (2015) 0.75
Genetics of the ghrelin system. Endocr Dev (2013) 0.75
[Treatment of acromegaly]. Orv Hetil (2010) 0.75
Preface. Handb Clin Neurol (2014) 0.75
[Familial isolated pituitary adenoma syndrome]. Orv Hetil (2011) 0.75
Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetes. J Clin Endocrinol Metab (2007) 0.75